Insider · CIK 0001913264
Ngar Yee Louie
Files at MAIA (MAIA Biotechnology, Inc.). First filing Dec 23, 2025, latest Dec 23, 2025.
In brief
Ngar Yee Louie files SEC Form 4 as director at MAIA (MAIA Biotechnology, Inc.). Since Dec 23, 2025, Ngar Yee Louie has reported 1 open-market buy worth $100k and 0 open-market sells worth $0, the latest filed on Dec 23, 2025.
A track record needs three past buys with six months of prices behind them; Ngar Yee Louie has 0, so none is measured yet.
The newest scored trade: bought $100k of MAIA on Dec 22, 2025, filed Dec 23, 2025, scored 51 (moderate). In the last 12 months: 1 buy worth $100k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MAIA: MAIA Biotechnology, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | MAIA Biotechnology, Inc. | $100k 81,699 shares | +7% | +53% from low-46% from high |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +39,634 | $0.00 | $0 | 39,634 | 11 d ago |
| Jun 30, 2026 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +32,630 | $0.00 | $0 | 32,630 | Jul 2, 2026 |
| Mar 31, 2026 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +33,748 | $0.00 | $0 | 33,748 | Apr 2, 2026 |
| Dec 31, 2025 | MAIA MAIA Biotechnology, Inc. | AGrant or award Optionsderivative | +29,789 | $0.00 | $0 | 29,789 | Jan 5, 2026 |
| Dec 22, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stock | +81,699 | $1.22 | $100k | 1,248,888 | Dec 23, 2025 |
| Dec 22, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Stock Optionsderivative | +81,699 | $1.36 | $111k | 81,699 | Dec 23, 2025 |
| Oct 2, 2025 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +25,331 | $0.00 | $0 | 25,331 | Oct 6, 2025 |
| Jun 30, 2025 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +25,232 | $0.00 | $0 | 25,232 | Jul 2, 2025 |
| Apr 4, 2025 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +26,304 | $0.00 | $0 | 26,304 | Apr 8, 2025 |
Questions about Ngar Yee Louie
Answered from the filings on this page, as of the latest one.
Is Ngar Yee Louie buying or selling?
In the last 12 months Ngar Yee Louie reported 1 open-market buy worth $100k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $100k of MAIA on Dec 22, 2025. Grants, option exercises and tax withholding are not counted.
How did Ngar Yee Louie's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ngar Yee Louie has 0.
Where does Ngar Yee Louie file Form 4?
Ngar Yee Louie has filed Form 4 at MAIA (MAIA Biotechnology, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.